Milestone Pharmaceuticals Inc (MIST) Stock Analysis

Milestone Pharmaceuticals Inc (MIST) is a publicly traded company in the HEALTHCARE sector. It trades at $1.32, carries a market capitalization of $169.32M. This page summarizes the public market data, fundamentals, and frequently asked questions for MIST, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.32
• Market Cap: $169.32M
• EPS: $-0.64
• 52-Week High: $3.06
• 52-Week Low: $1.00

Market Sentiment

Milestone Pharmaceuticals Inc currently has a Bullish sentiment score of 0.49.

About Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc. (MIST) is an innovative biopharmaceutical company based in Montreal, dedicated to developing advanced therapies for cardiovascular conditions. The company's robust pipeline is designed to address significant unmet medical needs, leveraging sophisticated clinical research methodologies to create transformative treatments. Milestone's commitment to enhancing patient outcomes positions it as a vital contender in the healthcare sector, offering institutional investo...

GNG Research Analysis

GNG Research scores Milestone Pharmaceuticals Inc (MIST) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MIST.

Frequently Asked Questions

Does MIST pay dividends?

Milestone Pharmaceuticals Inc (MIST) does not currently pay a regular dividend.

What is MIST's market cap?

Milestone Pharmaceuticals Inc (MIST) has a market capitalization of $169.32M with a current stock price of $1.32.